New Non-Executive Director

Deltex Medical Group PLC
07 April 2008

                            Deltex Medical Group plc

Senior corporate financier joins board as non-executive director

7 April 2008 - Deltex Medical Group plc ('Deltex Medical' or the 'Company'), the
UK's leading haemodynamic monitoring company, today announces the appointment of
Charles Julian Cazalet, aged 60, as a non-executive director with immediate
effect.

Julian Cazalet was, until December 2007, a Managing Director - Corporate Finance
at JPMorgan Cazenove.  After graduating in Economics from Cambridge he qualified
as a Chartered Accountant with Whinney Murray before joining Cazenove & Co. in
1973. He became a Partner in 1978.  From 1989 he worked in Corporate Finance,
firstly in Equity Capital Markets and subsequently advising listed companies.

He serves as a Director of Herald Investment Trust plc and as a Director of a
charitable company, White Ensign Association Limited.

Mr Cazalet currently owns 1,250,000 ordinary shares in the Company, representing
1.35% of the total voting rights.

Deltex Medical's Chairman, Nigel Keen commented:

'Julian brings with him a wealth of experience that will help us shape the
future strategy of Deltex Medical as the Company continues to grow and evolve. I
believe that Julian's expertise in advising listed companies at all stages of
their development will prove invaluable as Deltex Medical reinforces its
position as a leading global manufacturer of medical device technologies.'

Julian Cazalet, commented:

'I am delighted to be joining the Board of Deltex Medical. The Company's
world-leading technology brings benefits to patients through better outcomes
that lead to shorter hospital stays and to healthcare providers by reducing the
time spent in hospital, thereby minimising costs. Deltex's technology enables
the delivery of a new standard of care for patients undergoing surgery which is
being adopted ever more enthusiastically worldwide'.

There are no other details required to be disclosed under paragraph (g) of
Schedule 2 of the AIM rules.

For further information, please contact:-

Deltex Medical Group plc                        01243 774 837
Nigel Keen, Chairman                            [e-mail]
Andy Hill, Chief Executive                      [e-mail]
Ewan Phillips, Finance Director                 [e-mail]

Gavin Anderson & Company                        0207 554 1400
Deborah Walter                                  [e-mail]
Robert Speed                                    [e-mail]
Stuart Macaulay                                 [e-mail]

Charles Stanley Securities
Nominated Adviser                               020 7149 6000
Philip Davies                                   [e-mail]
Russell Cook                                    [e-mail]



                      This information is provided by RNS
            The company news service from the London Stock Exchange
           FSSSIRIIT